Tozuleristide - Blaze Bioscience

Drug Profile

Tozuleristide - Blaze Bioscience

Alternative Names: BLZ-100; Chlorotoxin conjugated to indocyanine green dye - Blaze Bioscience; CyTP-007; Tumour paint

Latest Information Update: 20 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Blaze Bioscience
  • Class Biological toxins; Drug conjugates; Imaging agents; Indoles; Peptides
  • Mechanism of Action Diagnostic imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Brain cancer
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Breast cancer; Glioma; Skin cancer; Soft tissue sarcoma

Most Recent Events

  • 06 Jul 2018 Blaze Bioscience plans a phase II/III trial for CNS cancer (Diagnosis, In adolescents, In adults, In children, In infants) in Unknown country (IV), in August 2018 , (NCT03579602)
  • 01 Jun 2018 Pharmacokinetics data from two phase I trials in Glioma (Diagnosis, In adults, In children, In elderly) presented at the 54th Annual Meeting of the American Society of Clinical Oncology
  • 30 Apr 2018 QC feedback incorporated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top